SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that it has installed the first two Nevisense Systems at Advanced Dermatology and Cosmetics Surgery (“ADCS”) – the nation’s premier dermatology group.
The Nevisense systems are now operational at ADCS’ Windermere, Florida location led by Dr. Bill Steffes.
This is the first of several sites planned to offer Nevisense as part of a joint-partnership rollout this year.
Based in Maitland, Florida, Advanced Dermatology and Cosmetic Surgery is the nation’s leading providers of dermatological services with over 150 sites of care located across 14 states.
“We take pride in providing our patients with access to the most advanced technology for the earliest detection of melanoma, when the disease is at its most curable stage.
Technological advances like Nevisense will not only improve outcomes for our patients, but also change the landscape for the future of skin cancer detection and we are thrilled to be a part of this advancement,” said Dr. Matt Leavitt, founder and CEO of Advanced Dermatology and Cosmetic Surgery.
“This is a terrific first step in our collaboration with ADCS after their decision to adopt our advanced skin cancer detection solutions.
Offering ADCS providers such as Dr. Bill Steffes state-of-the art technology means they will have more management options, helping them improve patient care and outcomes,” said Simon Grant, Chief Executive Officer of SciBase.
“Having the nation’s leading dermatology group, such as ADCS, adopt Nevisense, is a reflection of the increasing level of interest we see for SciBase’s skin disorders solutions” added Grant.
For more information, visit scibase.com